Epidemiological and statistical research on health problems of low and middle-income countries: MRC Tropical Epidemiology Group (TEG)
Lead Research Organisation:
London Sch of Hygiene and Trop Medicine
Department Name: Epidemiology and Population Health
Abstract
The mission of the MRC Tropical Epidemiology Group (TEG) is to help improve health in low- and middle-income countries (LMICs), by conducting research that identifies and evaluates effective interventions.
Infectious diseases, including malaria, HIV, tuberculosis (TB) and neglected tropical diseases (NTDs), remain a main focus of our research, as they are the leading causes of ill-health in Africa. In the next grant period, we will expand our research on emerging diseases, adolescent health and non-communicable diseases - particularly hypertension, diabetes and chronic obstructive pulmonary disease, which are major disease problems in LMICs. Our research focuses on conditions that are major causes of ill-health, and for which improved prevention or treatment leads directly to improved economic and social outcomes. The importance of these issues to the UK is highlighted in the 2015 Government strategy for overseas aid, on tackling global challenges in the national interest.
The scale-up of malaria control tools, primarily long-lasting insecticidal nets, and effective combination therapies, has prevented an estimated 663 million clinical malaria cases in sub-Saharan Africa since 2000, and has made malaria elimination an achievable goal in some countries. However, these gains may be threatened by insecticide resistance, drug-resistance, and resource-constraints. Within the next grant period, our focus will be on evaluating new tools, combining new and existing control strategies, and investigating sustainable and more effective deployment of these strategies.
For HIV, we focus on the goal that 90% of those living with HIV know their status, 90% of known HIV-positive individuals receive sustained ART, and 90% of individuals on ART have durable viral suppression. For example, we are leading a major trial in South Africa and Zambia to evaluate the impact of a combination prevention intervention on new cases of HIV in the community. The intervention includes household-based HIV testing and linkage-to-health services by community care providers, and immediate initiation of treatment delivered through routine healthcare services.
TEG research on TB includes studies to evaluate improved TB treatment strategies, improved diagnosis, prevention and control of drug-resistant TB, improved TB case finding and prevention, and evaluation of structural interventions (social support and monetary incentives) to control TB. For example, we are working on a trial to evaluate an improved electronic medication device for TB patients to reduce treatment failure and subsequent recurrence/retreatment in the absence of directly observed treatment.
We will continue our long-standing work on intervention strategies for the control and elimination of NTDs, and our more recent involvement in the control of outbreaks such as the Ebola and Zika virus outbreaks. We will also continue our work on the effectiveness of lay-health worker interventions to treat common mental disorders (depression and anxiety), focusing particularly on treatment of these conditions among adolescents, in whom over half of mental health disorders start.
Through the MRC Programme Grant, we leverage additional funding for research projects and support salaries for around 30 statisticians and epidemiologists, based at LSHTM. The grant is critical to enable us to recruit and retain these scientists, who have disease and methodological expertise in the design and analysis of epidemiological studies in LMICs. We collaborate with the MRC Units in The Gambia and Uganda, and over 50 other research institutes in LMICs. We will continue our initiatives to increase capacity in medical statistics in sub-Saharan Africa, for example by expanding the MRC TEG Fellowship scheme, which to date has trained 17 medical statisticians through a Masters in Medical Statistics at LSHTM, followed by a placement year. All are now working as medical statisticians in Africa.
Infectious diseases, including malaria, HIV, tuberculosis (TB) and neglected tropical diseases (NTDs), remain a main focus of our research, as they are the leading causes of ill-health in Africa. In the next grant period, we will expand our research on emerging diseases, adolescent health and non-communicable diseases - particularly hypertension, diabetes and chronic obstructive pulmonary disease, which are major disease problems in LMICs. Our research focuses on conditions that are major causes of ill-health, and for which improved prevention or treatment leads directly to improved economic and social outcomes. The importance of these issues to the UK is highlighted in the 2015 Government strategy for overseas aid, on tackling global challenges in the national interest.
The scale-up of malaria control tools, primarily long-lasting insecticidal nets, and effective combination therapies, has prevented an estimated 663 million clinical malaria cases in sub-Saharan Africa since 2000, and has made malaria elimination an achievable goal in some countries. However, these gains may be threatened by insecticide resistance, drug-resistance, and resource-constraints. Within the next grant period, our focus will be on evaluating new tools, combining new and existing control strategies, and investigating sustainable and more effective deployment of these strategies.
For HIV, we focus on the goal that 90% of those living with HIV know their status, 90% of known HIV-positive individuals receive sustained ART, and 90% of individuals on ART have durable viral suppression. For example, we are leading a major trial in South Africa and Zambia to evaluate the impact of a combination prevention intervention on new cases of HIV in the community. The intervention includes household-based HIV testing and linkage-to-health services by community care providers, and immediate initiation of treatment delivered through routine healthcare services.
TEG research on TB includes studies to evaluate improved TB treatment strategies, improved diagnosis, prevention and control of drug-resistant TB, improved TB case finding and prevention, and evaluation of structural interventions (social support and monetary incentives) to control TB. For example, we are working on a trial to evaluate an improved electronic medication device for TB patients to reduce treatment failure and subsequent recurrence/retreatment in the absence of directly observed treatment.
We will continue our long-standing work on intervention strategies for the control and elimination of NTDs, and our more recent involvement in the control of outbreaks such as the Ebola and Zika virus outbreaks. We will also continue our work on the effectiveness of lay-health worker interventions to treat common mental disorders (depression and anxiety), focusing particularly on treatment of these conditions among adolescents, in whom over half of mental health disorders start.
Through the MRC Programme Grant, we leverage additional funding for research projects and support salaries for around 30 statisticians and epidemiologists, based at LSHTM. The grant is critical to enable us to recruit and retain these scientists, who have disease and methodological expertise in the design and analysis of epidemiological studies in LMICs. We collaborate with the MRC Units in The Gambia and Uganda, and over 50 other research institutes in LMICs. We will continue our initiatives to increase capacity in medical statistics in sub-Saharan Africa, for example by expanding the MRC TEG Fellowship scheme, which to date has trained 17 medical statisticians through a Masters in Medical Statistics at LSHTM, followed by a placement year. All are now working as medical statisticians in Africa.
Technical Summary
The aim of TEG is to conduct cutting-edge epidemiological studies on health problems of low- and middle-income countries (LMICs). TEG will continue to have a major focus on the epidemiology and control of infectious diseases, with increased emphasis on evaluating delivery strategies for interventions of proven effectiveness. We will expand our research on emerging infectious diseases, adolescent health, non-communicable diseases and applied epidemiological methods. We will also expand our capacity building initiatives, including the TEG Fellowship scheme to train African statisticians. These issues are critical to the UK Government strategy for overseas aid, as indicated by the £1.5 billion Global Challenges Research Fund to support challenges in LMICs.
TEG malaria research includes assessing the scale-up and combination of malaria control tools, e.g. investigating sustainable and more effective deployment of long-lasting insecticidal nets, and effective combination therapies. For HIV, we focus on community-based approaches to improving HIV testing and linkage-to-care in sub-Saharan Africa, and interventions for key populations in high-incidence settings. Our TB research includes studies to evaluate improved TB treatment strategies, improved diagnosis, prevention and control of drug-resistant TB, improved case finding and prevention, and structural interventions. We will continue research on the control and elimination of NTDs, including the Ebola and Zika virus outbreaks. Finally, we conduct applied methodological work to advance the design and analysis of epidemiological studies in LMICs.
Through the Programme Grant, we will continue to leverage funding to recruit and retain a critical mass of scientists who have expertise in design and analysis of epidemiological studies in LMICs, and relevant disease-specific expertise. We collaborate closely with the African MRC Units and many other institutes in LMICs, with whom we published 700 papers in the past 5 year
TEG malaria research includes assessing the scale-up and combination of malaria control tools, e.g. investigating sustainable and more effective deployment of long-lasting insecticidal nets, and effective combination therapies. For HIV, we focus on community-based approaches to improving HIV testing and linkage-to-care in sub-Saharan Africa, and interventions for key populations in high-incidence settings. Our TB research includes studies to evaluate improved TB treatment strategies, improved diagnosis, prevention and control of drug-resistant TB, improved case finding and prevention, and structural interventions. We will continue research on the control and elimination of NTDs, including the Ebola and Zika virus outbreaks. Finally, we conduct applied methodological work to advance the design and analysis of epidemiological studies in LMICs.
Through the Programme Grant, we will continue to leverage funding to recruit and retain a critical mass of scientists who have expertise in design and analysis of epidemiological studies in LMICs, and relevant disease-specific expertise. We collaborate closely with the African MRC Units and many other institutes in LMICs, with whom we published 700 papers in the past 5 year
Planned Impact
Beneficiaries of our research include i) populations in low- and middle-income countries (LMICs) affected by the diseases which we research, ii) local and national stakeholders; iii) national and international policy makers; iv) scientists within TEG; v) our collaborators in LMICs; and vi) the wider academic community of global health researchers.
i) The diseases we focus on are malaria, HIV, TB, emerging and neglected diseases - including mental health, eye health and non-communicable diseases. Each of these disproportionately affect the poorest in resource-poor countries, and those marginalised from society. These diseases also have a substantial impact on national socio-economic development. By reducing the rates of important causes of ill health, we have the potential to alleviate poverty as well as improving life expectancy. Many of the studies we undertake involve community-based interventions focused on overcoming barriers to health service access and to minimize stigma and discrimination. This is a common issue for many of the diseases we work on, and particularly for HIV and mental health, and among some of the key populations that we focus on, including adolescents and high-risk groups.
ii) We engage with local and national stakeholders, as described in the Pathways to Impact statement, and they benefit directly, for example, from our studies to evaluate optimal strategies for delivery of interventions of known effectiveness (for example on integrating HIV and non-communicable disease treatment and care); or to improve efficiency or cost of interventions (for example the first trial of reduced dose human papillomavirus (HPV) vaccine in Tanzania, or the planned trial of fractional dose pneumococcal vaccine in Kenya).
iii) We are able to ensure that results from our research and other important studies help to inform new policies and guidelines, through our role on national and international advisory committees, including as Chair of the WHO Joint Technical Expert Group on Malaria Vaccines in Pivotal Phase 3 Trials & Beyond; and members of the UNAIDS Scientific Expert Panel, the scientific advisory committees of EDCTP and CEPI (Coalition for Epidemic Preparedness, Innovations), the WHO Technical Advisory Committee on Safe Male Circumcision, the WHO Evidence Review Group on Malaria in Pregnancy, the WHO Global Malaria Programme, Surveillance Monitoring and Evaluation Technical Advisory Group, and WHO Expert Working Groups on Lassa fever, Nipah virus and MERS Co-V vaccine Target Product Profiles.
iv) The Programme Grant enables us to sustain a strong critical mass of experienced statistical epidemiologists and to provide an actively supportive academic environment and mentorship for all our staff. We regularly review and encourage career development, support the development of Fellowship and research grant applications, and provide funds for training courses and conference attendance.
v) Our collaborators benefit directly from our research (see Letters of Support), as the Programme Grant enables us to provide consistent and continuous, disease-specific, statistical and epidemiological expertise that is in short supply in global health research. This leads to high-quality scientific outputs and new grant applications, which lead to population health benefits. We also have an impact on the careers of the MSc, PhD and post-doctoral students who we teach, supervise and mentor, both at LSHTM, through our Fellowship scheme and collaborative links, as described in the Case for Support and Academic Beneficiaries sections.
vi) We produce around 120 papers annually, and disseminate findings at international conferences in order to benefit to the wider academic community working on global health. This includes clinical epidemiologists, social scientists and laboratory scientists. In March 2021 we plan to hold a two-day symposium to increase the impact and reach of our research findings.
i) The diseases we focus on are malaria, HIV, TB, emerging and neglected diseases - including mental health, eye health and non-communicable diseases. Each of these disproportionately affect the poorest in resource-poor countries, and those marginalised from society. These diseases also have a substantial impact on national socio-economic development. By reducing the rates of important causes of ill health, we have the potential to alleviate poverty as well as improving life expectancy. Many of the studies we undertake involve community-based interventions focused on overcoming barriers to health service access and to minimize stigma and discrimination. This is a common issue for many of the diseases we work on, and particularly for HIV and mental health, and among some of the key populations that we focus on, including adolescents and high-risk groups.
ii) We engage with local and national stakeholders, as described in the Pathways to Impact statement, and they benefit directly, for example, from our studies to evaluate optimal strategies for delivery of interventions of known effectiveness (for example on integrating HIV and non-communicable disease treatment and care); or to improve efficiency or cost of interventions (for example the first trial of reduced dose human papillomavirus (HPV) vaccine in Tanzania, or the planned trial of fractional dose pneumococcal vaccine in Kenya).
iii) We are able to ensure that results from our research and other important studies help to inform new policies and guidelines, through our role on national and international advisory committees, including as Chair of the WHO Joint Technical Expert Group on Malaria Vaccines in Pivotal Phase 3 Trials & Beyond; and members of the UNAIDS Scientific Expert Panel, the scientific advisory committees of EDCTP and CEPI (Coalition for Epidemic Preparedness, Innovations), the WHO Technical Advisory Committee on Safe Male Circumcision, the WHO Evidence Review Group on Malaria in Pregnancy, the WHO Global Malaria Programme, Surveillance Monitoring and Evaluation Technical Advisory Group, and WHO Expert Working Groups on Lassa fever, Nipah virus and MERS Co-V vaccine Target Product Profiles.
iv) The Programme Grant enables us to sustain a strong critical mass of experienced statistical epidemiologists and to provide an actively supportive academic environment and mentorship for all our staff. We regularly review and encourage career development, support the development of Fellowship and research grant applications, and provide funds for training courses and conference attendance.
v) Our collaborators benefit directly from our research (see Letters of Support), as the Programme Grant enables us to provide consistent and continuous, disease-specific, statistical and epidemiological expertise that is in short supply in global health research. This leads to high-quality scientific outputs and new grant applications, which lead to population health benefits. We also have an impact on the careers of the MSc, PhD and post-doctoral students who we teach, supervise and mentor, both at LSHTM, through our Fellowship scheme and collaborative links, as described in the Case for Support and Academic Beneficiaries sections.
vi) We produce around 120 papers annually, and disseminate findings at international conferences in order to benefit to the wider academic community working on global health. This includes clinical epidemiologists, social scientists and laboratory scientists. In March 2021 we plan to hold a two-day symposium to increase the impact and reach of our research findings.
Organisations
- London Sch of Hygiene and Trop Medicine, United Kingdom (Lead Research Organisation)
- UNICEF, United States (Collaboration)
- University of Nairobi, Kenya (Collaboration)
- Malaria Consortium (Collaboration)
- WoMena, Uganda (Collaboration)
- National Health Laboratory (Collaboration)
- University of Cape Town (Collaboration)
- National Hospital of Pneumo-Phtisiology (Collaboration)
- Ipsos-MORI (Collaboration)
- University of Makeni (Collaboration)
- Harvard University (Collaboration)
- University of Lusaka (Collaboration)
- Research Institute for Health Sciences (IRSS) (Collaboration)
- University of Ibadan, Nigeria (Collaboration)
- University of Malawi, Malawi (Collaboration)
- Leiden University Medical Center (Collaboration)
- Kintampo Health Research Centre (Collaboration)
- Africa Health Research Institute (Collaboration)
- Organization for Public Health Interventions and Development (Collaboration)
- Ifakara Health Institute, Tanzania, United Republic of (Collaboration)
- KNCV Tuberculosis Foundation (Collaboration)
- University of Oxford, United Kingdom (Collaboration)
- National Institute for Medical Research (Collaboration)
- University of Ghana, Ghana (Collaboration)
- University of Bristol, United Kingdom (Collaboration)
- Fred Hutchinson Cancer Research Center (FHCRC) (Collaboration)
- Centro de Investigação em Saúde de Manhiça (Collaboration)
- University of Jos (Collaboration)
- World Health Organization (WHO) (Collaboration)
- University of East Anglia, United Kingdom (Collaboration)
- University Medical Centre Utrecht, Netherlands (Collaboration)
- Kamuzu Central Hospital (Collaboration)
- University of Birmingham, United Kingdom (Collaboration)
- Burnet Institute (Collaboration)
- Hiwot Fana Hospital (Collaboration)
- Mahidol University (Collaboration)
- Centre for Research in Infectious Diseases (CRID) (Collaboration)
- University of Accra (Collaboration)
- University of Copenhagen, Denmark (Collaboration)
- Kilimanjaro Christian Medical Centre (KCMS) (Collaboration)
- University of Sussex, United Kingdom (Collaboration)
- Wellcome Trust, LONDON (Collaboration)
- Peekvsion (Collaboration)
- Ministry of Health and Child Welfare of the Republic of Zimbabwe (Collaboration)
- Ministry of Health, Uganda (Collaboration)
- Calderdale and Huddersfield NHS Foundation Trust (Collaboration)
- The SHM Foundation (Collaboration)
- University College London, United Kingdom (Collaboration)
- University Cheikh Anta Diop de Dakar (Collaboration)
- National University of Kyiv Mohyla Academy (Collaboration)
- University of Tours (Collaboration)
- Zambart (Collaboration)
- Christian Medical College Vellore (Collaboration)
- Aga Khan University (Collaboration)
- HealthRight International (Collaboration)
- University of Bordeaux I, France (Collaboration)
- Queen Mary, University of London, United Kingdom (Collaboration)
- Government of Zimbabwe (Collaboration)
- Medicines for Malaria Venture (MMV) (Collaboration)
- National Institute of Health and Medical Research (INSERM) (Collaboration)
- Njala University, Sierra Leone (Collaboration)
- Cote D'Ivoire's National Institute of Public Health (Collaboration)
- MRC/UVRI Uganda Research Unit on AIDS, Uganda (Collaboration)
- Pasteur Institute of Madagascar (Collaboration)
- Monash University, Australia (Collaboration)
- St George's University of London, United Kingdom (Collaboration)
- Imperial College London, United Kingdom (Collaboration)
- Sangath (Collaboration)
- Stellenbosch University, South Africa (Collaboration)
- Haramaya University (Collaboration)
- Medical Research Council (Collaboration)
- Sophia University (Collaboration)
- Universidade de São Paulo (Collaboration)
- University of Bamako (Collaboration)
- Desmond Tutu HIV Foundation (Collaboration)
- University of Zimbabwe, Zimbabwe (Collaboration)
- Pasteur Institute, Morocco (Collaboration)
- Kenyan Institute for Medical Research (KEMRI) (Collaboration)
- Biomedical Research and Training Inst, Zimbabwe (Collaboration)
- Royal Veterinary College, United Kingdom (Collaboration)
- Johns Hopkins University, United States (Collaboration)
Publications
Abaasa A
(2019)
Use of reliable contraceptives and its correlates among women participating in Simulated HIV vaccine efficacy trials in key-populations in Uganda.
in Scientific reports
Abotsi RE
(2021)
Prevalence and antimicrobial resistance profiles of respiratory microbial flora in African children with HIV-associated chronic lung disease.
in BMC infectious diseases
Accrombessi M
(2021)
Assessing the efficacy of two dual-active ingredients long-lasting insecticidal nets for the control of malaria transmitted by pyrethroid-resistant vectors in Benin: study protocol for a three-arm, single-blinded, parallel, cluster-randomized controlled trial.
in BMC infectious diseases
Alexander N
(2020)
Spatial spillover analysis of a cluster-randomized trial against dengue vectors in Trujillo, Venezuela.
in PLoS neglected tropical diseases
Alexander NDE
(2020)
Spatiotemporal Analysis of the Population Risk of Congenital Microcephaly in Pernambuco State, Brazil.
in International journal of environmental research and public health
Anaya-Izquierdo K
(2021)
Spatial regression and spillover effects in cluster randomized trials with count outcomes.
in Biometrics
| Title | STAMP film |
| Description | An 8 minute film describing the STAMP trial. Clinical trial coordinators and research staff recruiting and following-up patients and laboratory staff, and the international trial coordinator were interviewed. |
| Type Of Art | Film/Video/Animation |
| Year Produced | 2018 |
| Impact | Film shown at the Steve Lawn Memorial lecture, March 2018. Over 200 views https://www.youtube.com/watch?v=CoP5GIfiMe8&t=1s [full version] https://www.youtube.com/watch?v=LYHEFQsE7HE&t=12s [social media version] |
| URL | https://www.youtube.com/watch?v=CoP5GIfiMe8&t=1s |
| Description | B-Gap |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| Impact | It is now easier, quicker, cheaper and less intrusive for parents to get their children tested for HIV |
| Description | Design of treatment trials for 2019-nCoV cases (PS, TE) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Impact | Should identify more rapidly increases in survival and quality of life |
| Description | MVIP-Programme Advisory Group Meeting |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a advisory committee |
| Impact | The idea of this meeting is inform a decision on routine use of the RTS,S malaria vaccine for the first time, so could lead to increases in survival, quality of life, decreases in (malaria) incidence across sub-saharan Africa. The influence of our trial which is feeding into this will mainly relate to West Africa. |
| Description | PopART and policy for HIV testing and treatment |
| Geographic Reach | Africa |
| Policy Influence Type | Citation in other policy documents |
| Impact | Trial findings have informed design and delivery of HIV testing services in S Africa and WHO deliberations on implementation of universal testing and treatment |
| URL | http://hivst.org/policy/zambia |
| Description | Prioritisation of 2019-nCoV vaccines (PS) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Impact | Should identify more rapidly increases in survival and quality of life |
| Description | STAMP - Article in Aidsmap following publication of CID paper |
| Geographic Reach | Africa |
| Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
| URL | http://www.aidsmap.com/news/feb-2020/alarmingly-high-mortality-hospitalised-patients-hivtb-co-infect... |
| Description | STAMP - TAG |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
| URL | http://www.treatmentactiongroup.org/content/activists-call-countries-and-donors-immediately-scale-us... |
| Guideline Title | The use of lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis and screening of active tuberculosis in people living with HIV |
| Description | STAMP - preparatory work to trial cited in WHO 2019 LAM policy update |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| URL | https://www.who.int/tb/publications/use-of-lf-lam-tb-hiv/en/ |
| Description | UK Government Period Poverty Taskforce |
| Geographic Reach | National |
| Policy Influence Type | Membership of a guideline committee |
| URL | https://www.gov.uk/government/news/period-poverty-taskforce-minister-announces-next-steps-on-menstru... |
| Description | WHO DAT Task Force |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a advisory committee |
| Impact | It's a relatively new group so not an opportunity to influence on policy, practice, patients or the public - but will do so in the future |
| Description | WHO HIV-VL |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a advisory committee |
| Impact | None yet |
| Description | WHO Technical Consultation on Chemoprevention (MC) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a advisory committee |
| Impact | May lead to more flexible recommendations on chemopreventive approaches allowing its use in a wider area and/or subsequent policy changes |
| Description | WHO Technical Consultation on SMC (MC) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a advisory committee |
| Impact | May lead to more flexible recommendations on SMC allowing its use in a wider area and/or subsequent policy changes |
| Description | (RPC): FILLING THE GAPS IN EVIDENCE: BUILDING STRONGER AND MORE RESILIENT HEALTH SYSTEMS - RAFT |
| Amount | £7,812,831 (GBP) |
| Organisation | UK Department for International Development |
| Sector | Public |
| Country | United Kingdom |
| Start | 05/2020 |
| End | 04/2026 |
| Description | AlCohol use in HumanitariAN settings: a programme of work to address alcohol and associated adversities among conflict-affected populations in UGanda and UkrainE (CHANGE) |
| Amount | £3,803,801 (GBP) |
| Funding ID | 219468/Z/19/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 05/2020 |
| End | 04/2025 |
| Description | Attractant Targeted Sugar Bates (ATSB) trial |
| Amount | $6,499,963 (USD) |
| Organisation | IVCC |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 11/2018 |
| End | 04/2021 |
| Description | Building a sustainable model to promote menstrual, sexual and reproductive health (MSRH) amongst secondary school girls in Tanzania |
| Amount | £676,305 (GBP) |
| Funding ID | MR/T040297/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 05/2020 |
| End | 05/2023 |
| Description | Combination prevention and strategies for HIV control: In-depth analysis of data from the HPTN 071 (PopART) trial |
| Amount | $1,198,185 (USD) |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 02/2020 |
| End | 01/2022 |
| Description | Cross-sectional survey to measure additional outcomes for the HPTN 071 (PopART study) |
| Amount | $700,000 (USD) |
| Organisation | International Initiative for Impact Evaluation |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 08/2019 |
| End | 10/2020 |
| Description | Crowdsourcing with adolescents in Senegal |
| Amount | £323,754 (GBP) |
| Funding ID | MR/S023712/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 09/2019 |
| End | 08/2021 |
| Description | DfID - SUCCEED (SUpport, Comprehensive Care and EmpowErment for people with psychosocial Disabilities in Sub-Saharan Africa) |
| Amount | £56,510 (GBP) |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 05/2020 |
| End | 04/2025 |
| Description | Effects of metronidazole plus intermittent preventive treatment of malaria in pregnancy on birth outcomes: a randomised controlled trial in Zambia |
| Amount | £2,545,958 (GBP) |
| Funding ID | MR/S004998/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 11/2018 |
| End | 10/2022 |
| Description | Genital InFlammation Test (GIFT) for HIV prevention and reproductive health: point-of-care cytokine biomarker lateral flow test for asymptomatic inflammatory sexually transmitted infections (STIs) and bacterial vaginosis (BV |
| Amount | € 3,508,462 (EUR) |
| Funding ID | RIA2020I-3297 |
| Organisation | Sixth Framework Programme (FP6) |
| Department | European and Developing Countries Clinical Trials Partnership |
| Sector | Public |
| Country | Netherlands |
| Start | 03/2021 |
| End | 03/2024 |
| Description | Insecticide treated eave nets and window screens for malaria control |
| Amount | £212,405 (GBP) |
| Funding ID | MR/T003677/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 01/2020 |
| End | 06/2021 |
| Description | MRC PHIND - Improving management of self-reported abnormal vaginal discharge in rural north India |
| Amount | £150,000 (GBP) |
| Funding ID | MR/T026979/1 |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 01/2021 |
| End | 06/2022 |
| Description | Male partner-assisted contact tracing for HIV and tuberculosis in Malawi: an adaptive multi-arm multi-stage randomised trial (mPATCH-TB) |
| Amount | £112,515 (GBP) |
| Funding ID | MR/R019762/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 05/2018 |
| End | 04/2020 |
| Description | Medical-Detection Dogs to Identify People with SARS-CoV-2 |
| Amount | £1,155,120 (GBP) |
| Organisation | Department of Health (DH) |
| Sector | Public |
| Country | United Kingdom |
| Start | 05/2020 |
| End | 02/2021 |
| Description | Menstrual health interventions, schooling and mental health symptoms among Ugandan students (MENISCUS): a school-based cluster-randomised trial |
| Amount | £3,265,055 (GBP) |
| Funding ID | MR/V005634/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 11/2020 |
| End | 10/2023 |
| Description | NIH - IMPlementation of evidence based facility and community interventions to reduce the treatment gap for depRESSion (IMPRESS) |
| Amount | $2,609,843 (USD) |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 07/2020 |
| End | 04/2024 |
| Description | OPT SMC - Optimizing the impact of Seasonal Malaria Chemoprevention: improving delivery & building capacity for evaluation |
| Amount | € 530,296 (EUR) |
| Funding ID | CSA2018HS-2520-OPT-SMC |
| Organisation | Sixth Framework Programme (FP6) |
| Department | European and Developing Countries Clinical Trials Partnership |
| Sector | Public |
| Country | Netherlands |
| Start | 05/2020 |
| End | 04/2024 |
| Description | Operations research to measure the effectiveness of a peer-led mental health intervention on virological suppression and mental health among adolescents with HIV in Zimbabwe (ALHIV Adherence - Mental Health) |
| Amount | $40,202 (USD) |
| Organisation | AfricAid |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 02/2019 |
| End | 08/2020 |
| Description | Optimising seasonal malaria chemoprevention and seasonal vaccination in childhood to address the resurgent malaria burden in Africa |
| Amount | £916,159 (GBP) |
| Funding ID | 220658/Z/20/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 01/2021 |
| End | 12/2026 |
| Description | Perceptions, knowledge and use (and mis-use) of over the counter analgesics in East and Southern Africa |
| Amount | £20,000 (GBP) |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 10/2019 |
| End | 03/2020 |
| Description | Randomised controlled trial of cipro vs standard of care in plague |
| Amount | £1,588,565 (GBP) |
| Funding ID | 216273/Z/19/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 11/2019 |
| End | 04/2023 |
| Description | Risk factors for genital inflammation among women at high risk of HIV in Uganda: a mixed-method, longitudinal analysis |
| Amount | £772,976 (GBP) |
| Funding ID | MR/R023182/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 01/2019 |
| End | 12/2021 |
| Description | STIs in CHIEDZA |
| Amount | £1,009,735 (GBP) |
| Funding ID | MR/T040327/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2020 |
| End | 07/2023 |
| Description | Spatial Intelligence System for precision larviciding |
| Amount | $796,731 (USD) |
| Organisation | IVCC |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 01/2018 |
| End | 09/2020 |
| Description | TB MATE |
| Amount | $73,273 (USD) |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 06/2019 |
| End | 11/2021 |
| Description | TREATS-COVID - Understanding the Epidemiology of SARS-CoV-2 and the inter-relation of COVID-19 with TB and HIV in Zambia |
| Amount | € 82,310 (EUR) |
| Funding ID | RIA2020EF-3004 |
| Organisation | Sixth Framework Programme (FP6) |
| Department | European and Developing Countries Clinical Trials Partnership |
| Sector | Public |
| Country | Netherlands |
| Start | 07/2020 |
| End | 12/2021 |
| Description | The Bioko Island Malaria Elimination Project (BIMEP) |
| Amount | £40,203 (GBP) |
| Organisation | Medical Care Development |
| Sector | Hospitals |
| Country | United States |
| Start | 01/2019 |
| End | 12/2019 |
| Description | The epidemiology of scrub typhus and rickettisial infections in a highly endemic rural setting in South India: Population-based Cohort Study. |
| Amount | £767,928 (GBP) |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 01/2020 |
| End | 12/2022 |
| Description | To enhance the Public Health and Social Measures (PHSM) dataset through work with WHO |
| Amount | £126,291 (GBP) |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Global |
| Start | 10/2020 |
| End | 10/2021 |
| Description | UK-Brazil Joint Centre for Arbovirus Discovery, Diagnosis, Genomics and Epidemiology (CADDE) |
| Amount | £1,164,840 (GBP) |
| Funding ID | MR/S019510/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 04/2019 |
| End | 03/2022 |
| Description | Unlocking potential: developing innovative adolescent screening visits for health promotion, prevention and treatment in low-resource settings |
| Amount | £1,222,092 (GBP) |
| Funding ID | MR/T043156/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 02/2021 |
| End | 01/2025 |
| Description | Zvatinoda! (What we want!): Increasing demand and uptake of sexual and reproductive health services by young people in Zimbabwe |
| Amount | £151,520 (GBP) |
| Funding ID | MR/T003200/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 09/2019 |
| End | 02/2021 |
| Title | Developing tools for population estimation methods (CG) |
| Description | Developing tools for population estimation methods |
| Type Of Material | Improvements to research infrastructure |
| Year Produced | 2019 |
| Provided To Others? | Yes |
| Impact | Tool available and used for estimating populations cheaply and rapidly. Used by MITU on other research projects. Also used by Lake Victoria Consortium. Method feeding into to other research around population estimation and currently in discussions with Gates Foundation for use in EPI and other vaccine work. |
| Title | ART and HPV |
| Description | Data from a systematic review on ART and HPV infection |
| Type Of Material | Database/Collection of data |
| Year Produced | 2017 |
| Provided To Others? | Yes |
| Impact | None yet |
| URL | http://datacompass.lshtm.ac.uk |
| Title | Breathe |
| Description | BREATHE trial dataset |
| Type Of Material | Database/Collection of data |
| Year Produced | 2021 |
| Provided To Others? | Yes |
| Impact | None yet |
| URL | http://datacompass.lshtm.ac.uk |
| Title | Data for Thinking Healthy Programme India trial (THPP-India) |
| Description | An anonymised dataset of 280 women (one row per woman) who gave informed consent to participate in an individually-randomised, parallel, superiority, controlled trial in Goa, India in 2014-2016. The intervention was an adapted version of the Thinking Healthy Programme, delivered by peers; the control was enhanced usual care. Further details are available in the published protocol and paper. The dataset contains records of variables on stratified randomisation, socio-demographic information, depression and related outcomes, and therapy adherence. Visits occurred at baseline, and 3 and 6 months post-natal. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2018 |
| Provided To Others? | Yes |
| Impact | None yet |
| URL | http://datacompass.lshtm.ac.uk/id/eprint/793 |
| Title | Data for Thinking Healthy Programme Pakistan trial (THPP-Pakistan) |
| Description | An anonymised dataset of 570 women (one row per woman) who gave informed consent to participate in a cluster randomised, parallel, superiority, controlled trial in Rawalpindi, Pakistan in 2014-2017. The intervention was an adapted version of the Thinking Healthy Programme, delivered by peers; the control was enhanced usual care. Further details are available in the published protocol and paper. The dataset contains records of variables on stratified randomisation and clusters, socio-demographic information, depression and related outcomes, and therapy adherence. Visits occurred at baseline, and 3 and 6 months post-natal. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2018 |
| Provided To Others? | Yes |
| Impact | None yet |
| URL | http://datacompass.lshtm.ac.uk/id/eprint/794 |
| Title | Ebola Contact Tracing Study data |
| Description | The collection contains four datasets captured in the Ebola Contact Tracing Study: [1] 'summary_data_cases' contains details of the 41 confirmed Ebola cases included in the study; [2] 'app_data_contacts' contains details of the 646 Ebola contacts registered on the Ebola Contact Tracing App (ECT) smartphone app. These originate from 18 Ebola cases (16 were laboratory confirmed and 2 were "secret burials" that were not confirmed); [3] 'paper_data_contacts' describes 408 Ebola contacts who were identified from 25 Ebola cases for monitoring using the standard paper-based system for contact tracing; and [4] 'main_analysis_dataset' contains information on 804 Ebola contacts and their contact tracing monitoring status collected using both the ECT app and paper-based system. THESE DATASETS ARE EMBARGOED UNTIL 1st JUNE 2019. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2019 |
| Provided To Others? | Yes |
| Impact | None yet |
| URL | http://datacompass.lshtm.ac.uk/id/eprint/1069 |
| Title | Friendship Bench |
| Description | Friendship Bench dataset |
| Type Of Material | Database/Collection of data |
| Year Produced | 2021 |
| Provided To Others? | Yes |
| Impact | none yet |
| URL | http://datacompass.lshtm.ac.uk |
| Title | PREMIUM twelve-month follow-up trial: Clinical Outcomes and Cost-effectiveness dataset from the Counselling for Alcohol Problems (CAP) RCT |
| Description | Datasets for the two PREMIUM trials |
| Type Of Material | Database/Collection of data |
| Year Produced | 2017 |
| Provided To Others? | Yes |
| Impact | None yet |
| URL | http://datacompass.lshtm.ac.uk/514/ |
| Title | PREMIUM twelve-month follow-up trial: Clinical Outcomes and Cost-effectiveness dataset from the Healthy Activity Program (HAP) RCT |
| Description | Datasets for the two PREMIUM trials |
| Type Of Material | Database/Collection of data |
| Year Produced | 2017 |
| Provided To Others? | Yes |
| Impact | None yet |
| URL | http://datacompass.lshtm.ac.uk/513/ |
| Title | TB FastTrack |
| Description | Data from the TB FastTrack CRT |
| Type Of Material | Database/Collection of data |
| Year Produced | 2019 |
| Provided To Others? | Yes |
| Impact | None yet |
| URL | http://datacompass.lshtm.ac.uk |
| Title | WHO NPI Database |
| Description | global database on public health and social measures (PHSM) implemented by countries to reduce the spread of COVID-19. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | • Firstly we developed a taxonomy with WHO to allow the data to be coded. This taxonomy is now widely used by several other groups who collect their own datasets. So Both within WHO and external groups there are several datasets related to public health and social measures (PHSM) that are based on our taxonomy. • Secondly we developed a set of core variables required and ways of thinking about how we collect this type of policy information. Again these ideas have been adopted and influenced several of the largest trackers which are used widely. • The dataset was the first to bring together data from multiple sources and in doing this we produced mapping between the different groups datasets. We also introduced the idea that this was more sustainable and comprehensive way to collect data. It has led to the other groups establishing a network of PHSM trackers and many groups are now incorporating the same ideas into their datasets • The dataset itself is used by WHO, and is available through their website. They are currently in the process of incorporating the data into their covid19 dashboard. • The data is being used by modellers to look at the impact of policies on the pandemic, we are also using the data to look at what impact completeness of the trackers may have, as we have the ability to compare 5 different trackers. • Finally the dataset is being used to look at ML applications both in terms of automated bring different datasets together, coding existing data and to produce severity indicators |
| URL | https://github.com/lshtm-gis/WHO-PHSM |
| Description | ASCENT |
| Organisation | KNCV Tuberculosis Foundation |
| Country | Netherlands |
| Sector | Charity/Non Profit |
| PI Contribution | Lead on Ethiopian research; study design |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2019 |
| Description | CADDE (UK-Brazil Joint Centre for Arbovirus Discovery, Diagnosis, Genomics and Epidemiology) |
| Organisation | Universidade de São Paulo |
| Country | Brazil |
| Sector | Academic/University |
| PI Contribution | Study design and analysis, training |
| Collaborator Contribution | Genetics, public health, virology |
| Impact | Next Generation Sequencing workshop held in Sao Paulo, December 2019. Multidisciplinary: Genetics, public health, virology |
| Start Year | 2018 |
| Description | CADDE (UK-Brazil Joint Centre for Arbovirus Discovery, Diagnosis, Genomics and Epidemiology) |
| Organisation | University of Birmingham |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Study design and analysis, training |
| Collaborator Contribution | Genetics, public health, virology |
| Impact | Next Generation Sequencing workshop held in Sao Paulo, December 2019. Multidisciplinary: Genetics, public health, virology |
| Start Year | 2018 |
| Description | CADDE (UK-Brazil Joint Centre for Arbovirus Discovery, Diagnosis, Genomics and Epidemiology) |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Study design and analysis, training |
| Collaborator Contribution | Genetics, public health, virology |
| Impact | Next Generation Sequencing workshop held in Sao Paulo, December 2019. Multidisciplinary: Genetics, public health, virology |
| Start Year | 2018 |
| Description | CHANGE |
| Organisation | HealthRight International |
| Country | United States |
| Sector | Hospitals |
| PI Contribution | Study design, analysis |
| Collaborator Contribution | Study design, implementation and evaluation |
| Impact | Multidisciplinary: alcohol use disorders, humanitarian health, clinical trials |
| Start Year | 2020 |
| Description | CHANGE |
| Organisation | HealthRight International |
| Country | United States |
| Sector | Hospitals |
| PI Contribution | Statistical input |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2020 |
| Description | CHANGE |
| Organisation | Johns Hopkins University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Study design, analysis |
| Collaborator Contribution | Study design, implementation and evaluation |
| Impact | Multidisciplinary: alcohol use disorders, humanitarian health, clinical trials |
| Start Year | 2020 |
| Description | CHANGE |
| Organisation | National University of Kyiv Mohyla Academy |
| Country | Ukraine |
| Sector | Academic/University |
| PI Contribution | Statistical input |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2020 |
| Description | CHANGE |
| Organisation | National University of Kyiv Mohyla Academy |
| Country | Ukraine |
| Sector | Academic/University |
| PI Contribution | Study design, analysis |
| Collaborator Contribution | Study design, implementation and evaluation |
| Impact | Multidisciplinary: alcohol use disorders, humanitarian health, clinical trials |
| Start Year | 2020 |
| Description | CHANGE |
| Organisation | University of Copenhagen |
| Country | Denmark |
| Sector | Academic/University |
| PI Contribution | Statistical input |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2020 |
| Description | CHI-S (E.Webb) |
| Organisation | Leiden University Medical Center |
| Country | Netherlands |
| Sector | Academic/University |
| PI Contribution | Study design, trial statistician |
| Collaborator Contribution | Study design; coordination; field activities; lab studies |
| Impact | None yet, papers in preparation. Multidisciplinary: epidemiology, public health, statistics, clinical trials |
| Start Year | 2020 |
| Description | CHI-S (E.Webb) |
| Organisation | MRC/UVRI Uganda Research Unit on AIDS |
| Country | Uganda |
| Sector | Public |
| PI Contribution | Study design, trial statistician |
| Collaborator Contribution | Study design; coordination; field activities; lab studies |
| Impact | None yet, papers in preparation. Multidisciplinary: epidemiology, public health, statistics, clinical trials |
| Start Year | 2020 |
| Description | CHI-S (E.Webb) |
| Organisation | Ministry of Health, Uganda |
| Country | Uganda |
| Sector | Public |
| PI Contribution | Study design, trial statistician |
| Collaborator Contribution | Study design; coordination; field activities; lab studies |
| Impact | None yet, papers in preparation. Multidisciplinary: epidemiology, public health, statistics, clinical trials |
| Start Year | 2020 |
| Description | CRT with time to event outcomes |
| Organisation | National Institute of Health and Medical Research (INSERM) |
| Country | France |
| Sector | Academic/University |
| PI Contribution | Statistical support |
| Collaborator Contribution | Design, implementation, and analysis |
| Impact | None yet |
| Start Year | 2019 |
| Description | Clinical trial - MONART |
| Organisation | Africa Health Research Institute |
| Country | South Africa |
| Sector | Charity/Non Profit |
| PI Contribution | study design; statistical advice; analysis |
| Collaborator Contribution | design, implementation, specialist clinical expertise, information technology |
| Impact | None yet |
| Start Year | 2020 |
| Description | Clinical trial - MONART |
| Organisation | University of Cape Town |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | study design; statistical advice; analysis |
| Collaborator Contribution | design, implementation, specialist clinical expertise, information technology |
| Impact | None yet |
| Start Year | 2020 |
| Description | Clinical trial - MONART |
| Organisation | University of Sussex |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | study design; statistical advice; analysis |
| Collaborator Contribution | design, implementation, specialist clinical expertise, information technology |
| Impact | None yet |
| Start Year | 2020 |
| Description | EDCTP GIFT |
| Organisation | Burnet Institute |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | To develop guidelines for the integration of the GIFT device into current STI/BV management strategies in Africa |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2021 |
| Description | EDCTP GIFT |
| Organisation | Desmond Tutu HIV Foundation |
| Country | South Africa |
| Sector | Charity/Non Profit |
| PI Contribution | To develop guidelines for the integration of the GIFT device into current STI/BV management strategies in Africa |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2021 |
| Description | EDCTP GIFT |
| Organisation | Organization for Public Health Interventions and Development |
| Country | Zimbabwe |
| Sector | Charity/Non Profit |
| PI Contribution | To develop guidelines for the integration of the GIFT device into current STI/BV management strategies in Africa |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2021 |
| Description | EDCTP GIFT |
| Organisation | Pasteur Institute of Madagascar |
| Country | Madagascar |
| Sector | Academic/University |
| PI Contribution | To develop guidelines for the integration of the GIFT device into current STI/BV management strategies in Africa |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2021 |
| Description | EDCTP GIFT |
| Organisation | Pasteur Institute, Morocco |
| Country | Morocco |
| Sector | Public |
| PI Contribution | To develop guidelines for the integration of the GIFT device into current STI/BV management strategies in Africa |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2021 |
| Description | EDCTP GIFT |
| Organisation | Sophia University Japan |
| Country | Japan |
| Sector | Academic/University |
| PI Contribution | To develop guidelines for the integration of the GIFT device into current STI/BV management strategies in Africa |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2021 |
| Description | EDCTP GIFT |
| Organisation | University Medical Center Utrecht (UMC) |
| Country | Netherlands |
| Sector | Academic/University |
| PI Contribution | To develop guidelines for the integration of the GIFT device into current STI/BV management strategies in Africa |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2021 |
| Description | EDCTP GIFT |
| Organisation | University of Cape Town |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | To develop guidelines for the integration of the GIFT device into current STI/BV management strategies in Africa |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2021 |
| Description | EDCTP TEBWA |
| Organisation | National Hospital of Pneumo-Phtisiology |
| Country | Benin |
| Sector | Hospitals |
| PI Contribution | Teaching, mentoring |
| Collaborator Contribution | Design, implementation |
| Impact | None yet |
| Start Year | 2021 |
| Description | ENTRANT |
| Organisation | Haramaya University |
| Country | Ethiopia |
| Sector | Academic/University |
| PI Contribution | Project lead/coordinator, teaching, mentoring |
| Collaborator Contribution | Mentoring, applicant selection |
| Impact | Project just started, none yet. |
| Start Year | 2021 |
| Description | ENTRANT |
| Organisation | Medical Research Council (MRC) |
| Department | Medical Research Council (MRC), MRC/UVRI Unit, Uganda |
| Country | Uganda |
| Sector | Academic/University |
| PI Contribution | Project lead/coordinator, teaching, mentoring |
| Collaborator Contribution | Mentoring, applicant selection |
| Impact | Project just started, none yet. |
| Start Year | 2021 |
| Description | ENTRANT |
| Organisation | Ministry of Health and Child Welfare of the Republic of Zimbabwe |
| Country | Zimbabwe |
| Sector | Public |
| PI Contribution | Project lead/coordinator, teaching, mentoring |
| Collaborator Contribution | Mentoring, applicant selection |
| Impact | Project just started, none yet. |
| Start Year | 2021 |
| Description | ENTRANT |
| Organisation | National Health Laboratory |
| Country | Botswana |
| Sector | Hospitals |
| PI Contribution | Project lead/coordinator, teaching, mentoring |
| Collaborator Contribution | Mentoring, applicant selection |
| Impact | Project just started, none yet. |
| Start Year | 2021 |
| Description | ENTRANT |
| Organisation | National Institute for Medical Research, Tanzania |
| Department | Mwanza Intervention Trials Unit (MITU) |
| Country | Tanzania, United Republic of |
| Sector | Public |
| PI Contribution | Project lead/coordinator, teaching, mentoring |
| Collaborator Contribution | Mentoring, applicant selection |
| Impact | Project just started, none yet. |
| Start Year | 2021 |
| Description | ENTRANT |
| Organisation | University of Nairobi |
| Country | Kenya |
| Sector | Academic/University |
| PI Contribution | Project lead/coordinator, teaching, mentoring |
| Collaborator Contribution | Mentoring, applicant selection |
| Impact | Project just started, none yet. |
| Start Year | 2021 |
| Description | ENTRANT |
| Organisation | Zambart |
| Country | Zambia |
| Sector | Public |
| PI Contribution | Project lead/coordinator, teaching, mentoring |
| Collaborator Contribution | Mentoring, applicant selection |
| Impact | Project just started, none yet. |
| Start Year | 2021 |
| Description | Estimands in Stepped Wedge Trials |
| Organisation | University College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Statistical support |
| Collaborator Contribution | Design, implementation, and analysis |
| Impact | No impact yet |
| Start Year | 2019 |
| Description | IMPACT-BP |
| Organisation | Africa Health Research Institute |
| Country | South Africa |
| Sector | Charity/Non Profit |
| PI Contribution | study design; statistical advice; analysis |
| Collaborator Contribution | design, implementation, specialist clinical expertise |
| Impact | None yet |
| Start Year | 2018 |
| Description | IMPACT-BP |
| Organisation | Harvard University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | study design; statistical advice; analysis |
| Collaborator Contribution | design, implementation, specialist clinical expertise |
| Impact | None yet |
| Start Year | 2018 |
| Description | IMPACT-BP |
| Organisation | University of Bordeaux |
| Country | France |
| Sector | Academic/University |
| PI Contribution | study design; statistical advice; analysis |
| Collaborator Contribution | design, implementation, specialist clinical expertise |
| Impact | None yet |
| Start Year | 2018 |
| Description | IMPACT-BP |
| Organisation | University of East Anglia |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | study design; statistical advice; analysis |
| Collaborator Contribution | design, implementation, specialist clinical expertise |
| Impact | None yet |
| Start Year | 2018 |
| Description | IMPRESS |
| Organisation | Sangath |
| Country | India |
| Sector | Charity/Non Profit |
| PI Contribution | Statistical input |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2020 |
| Description | INPUTT |
| Organisation | Fred Hutchinson Cancer Research Center (FHCRC) |
| Department | Statistical Center for HIV/AIDS Research and Prevention (SCHARP) |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Coordination, statistical analysis, publication |
| Collaborator Contribution | Analysis, publication |
| Impact | None yet |
| Start Year | 2020 |
| Description | INPUTT |
| Organisation | University of Oxford |
| Department | Big Data Institute |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Coordination, statistical analysis, publication |
| Collaborator Contribution | Analysis, publication |
| Impact | None yet |
| Start Year | 2020 |
| Description | INPUTT |
| Organisation | Zambart |
| Country | Zambia |
| Sector | Public |
| PI Contribution | Coordination, statistical analysis, publication |
| Collaborator Contribution | Analysis, publication |
| Impact | None yet |
| Start Year | 2020 |
| Description | ITENs |
| Organisation | Ifakara Health Institute |
| Country | Tanzania, United Republic of |
| Sector | Charity/Non Profit |
| PI Contribution | PI on grant |
| Collaborator Contribution | entomology |
| Impact | No impact yet |
| Start Year | 2020 |
| Description | Kintampo RTS,S safety study |
| Organisation | Kintampo Health Research Centre |
| Country | Ghana |
| Sector | Hospitals |
| PI Contribution | Statistical advisory role, help with analysis plans |
| Collaborator Contribution | Design, implementation, analysis, interpret |
| Impact | None yet |
| Start Year | 2020 |
| Description | Longitudinal CRTs |
| Organisation | Monash University |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Statistical support |
| Collaborator Contribution | Design, implementation, and analysis |
| Impact | Online tool. Paper submitted |
| Start Year | 2019 |
| Description | Lurkana HIV paediatric outbreak |
| Organisation | Aga Khan University |
| Country | Pakistan |
| Sector | Academic/University |
| PI Contribution | study statistician |
| Collaborator Contribution | fieldwork, study coordination, knowledge of setting, clinical input, political engagement |
| Impact | two publications, main results paper in progress. Multidisciplinary: epidemiology, molecular epidemiology |
| Start Year | 2019 |
| Description | MBIRA observational study |
| Organisation | Centro de Investigação em Saúde de Manhiça |
| Country | Mozambique |
| Sector | Charity/Non Profit |
| PI Contribution | design, analysis |
| Collaborator Contribution | clinical, field, project management |
| Impact | None yet |
| Start Year | 2020 |
| Description | MBIRA observational study |
| Organisation | Hiwot Fana Hospital |
| Country | Ethiopia |
| Sector | Hospitals |
| PI Contribution | design, analysis |
| Collaborator Contribution | clinical, field, project management |
| Impact | None yet |
| Start Year | 2020 |
| Description | MBIRA observational study |
| Organisation | Kamuzu Central Hospital |
| Country | Malawi |
| Sector | Hospitals |
| PI Contribution | design, analysis |
| Collaborator Contribution | clinical, field, project management |
| Impact | None yet |
| Start Year | 2020 |
| Description | MBIRA observational study |
| Organisation | Kilimanjaro Christian Medical Centre (KCMS) |
| Country | Tanzania, United Republic of |
| Sector | Hospitals |
| PI Contribution | design, analysis |
| Collaborator Contribution | clinical, field, project management |
| Impact | None yet |
| Start Year | 2020 |
| Description | MBIRA observational study |
| Organisation | Njala University, Sierra Leone |
| Country | Sierra Leone |
| Sector | Academic/University |
| PI Contribution | design, analysis |
| Collaborator Contribution | clinical, field, project management |
| Impact | None yet |
| Start Year | 2020 |
| Description | MBIRA observational study |
| Organisation | University of Accra |
| Country | Ghana |
| Sector | Academic/University |
| PI Contribution | design, analysis |
| Collaborator Contribution | clinical, field, project management |
| Impact | None yet |
| Start Year | 2020 |
| Description | MBIRA observational study |
| Organisation | University of Jos |
| Country | Nigeria |
| Sector | Academic/University |
| PI Contribution | design, analysis |
| Collaborator Contribution | clinical, field, project management |
| Impact | None yet |
| Start Year | 2020 |
| Description | MBIRA observational study |
| Organisation | University of Stellenbosch |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | design, analysis |
| Collaborator Contribution | clinical, field, project management |
| Impact | None yet |
| Start Year | 2020 |
| Description | MBIRA observational study |
| Organisation | University of Zimbabwe |
| Country | Zimbabwe |
| Sector | Academic/University |
| PI Contribution | design, analysis |
| Collaborator Contribution | clinical, field, project management |
| Impact | None yet |
| Start Year | 2020 |
| Description | MBIRA observational study |
| Organisation | Wellcome Trust |
| Department | KEMRI-Wellcome Trust Research Programme |
| Country | Kenya |
| Sector | Academic/University |
| PI Contribution | design, analysis |
| Collaborator Contribution | clinical, field, project management |
| Impact | None yet |
| Start Year | 2020 |
| Description | MBIRA observational study |
| Organisation | Wellcome Trust |
| Department | KEMRI-Wellcome Trust Research Programme, Uganda |
| Country | Uganda |
| Sector | Charity/Non Profit |
| PI Contribution | design, analysis |
| Collaborator Contribution | clinical, field, project management |
| Impact | None yet |
| Start Year | 2020 |
| Description | MENISCUS |
| Organisation | Medical Research Council (MRC) |
| Department | Medical Research Council (MRC), MRC/UVRI Unit, Uganda |
| Country | Uganda |
| Sector | Academic/University |
| PI Contribution | Overall lead; study design; analysis |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | No impact yet |
| Start Year | 2020 |
| Description | MENISCUS |
| Organisation | University College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Overall lead; study design; analysis |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | No impact yet |
| Start Year | 2020 |
| Description | MENISCUS |
| Organisation | WoMena, Uganda |
| Country | Uganda |
| Sector | Charity/Non Profit |
| PI Contribution | Overall lead; study design; analysis |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | No impact yet |
| Start Year | 2020 |
| Description | MERS-CoV in Jordan |
| Organisation | Royal Veterinary College (RVC) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Design of study and analysis of results |
| Collaborator Contribution | Fieldwork in, and knowledge of, Jordan and knowledge of camels and camel infections |
| Impact | None yet, two papers in preparation. Discipline: vet epidemiology |
| Start Year | 2016 |
| Description | MRC QMUL COMBI |
| Organisation | Queen Mary University of London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Statistical input |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2021 |
| Description | Matt's Wellcome Fellowship |
| Organisation | Imperial College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Project lead, study design, analysis |
| Collaborator Contribution | Specialist expertise |
| Impact | None yet |
| Start Year | 2021 |
| Description | Matt's Wellcome Fellowship |
| Organisation | Research Institute for Health Sciences (IRSS) |
| Country | Burkina Faso |
| Sector | Public |
| PI Contribution | Project lead, study design, analysis |
| Collaborator Contribution | Specialist expertise |
| Impact | None yet |
| Start Year | 2021 |
| Description | Matt's Wellcome Fellowship |
| Organisation | University Cheikh Anta Diop de Dakar |
| Country | Senegal |
| Sector | Academic/University |
| PI Contribution | Project lead, study design, analysis |
| Collaborator Contribution | Specialist expertise |
| Impact | None yet |
| Start Year | 2021 |
| Description | Matt's Wellcome Fellowship |
| Organisation | University of Bamako |
| Department | Malaria Research and Training Centre (MRTC) Bamako |
| Country | Mali |
| Sector | Academic/University |
| PI Contribution | Project lead, study design, analysis |
| Collaborator Contribution | Specialist expertise |
| Impact | None yet |
| Start Year | 2021 |
| Description | NPI database phase I |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | We developed a taxonomy with WHO to allow the data to be coded and we developed a taxonomy with WHO to allow the data to be coded. |
| Collaborator Contribution | Design, implementation, and analysis |
| Impact | • Firstly we developed a taxonomy with WHO to allow the data to be coded. This taxonomy is now widely used by several other groups who collect their own datasets. So Both within WHO and external groups there are several datasets related to public health and social measures (PHSM) that are based on our taxonomy. • Secondly we developed a set of core variables required and ways of thinking about how we collect this type of policy information. Again these ideas have been adopted and influenced several of the largest trackers which are used widely. • The dataset was the first to bring together data from multiple sources and in doing this we produced mapping between the different groups datasets. We also introduced the idea that this was more sustainable and comprehensive way to collect data. It has led to the other groups establishing a network of PHSM trackers and many groups are now incorporating the same ideas into their datasets • The dataset itself is used by WHO, and is available through their website. They are currently in the process of incorporating the data into their covid19 dashboard. • The data is being used by modellers to look at the impact of policies on the pandemic, we are also using the data to look at what impact completeness of the trackers may have, as we have the ability to compare 5 different trackers. • Finally the dataset is being used to look at ML applications both in terms of automated bring different datasets together, coding existing data and to produce severity indicators |
| Start Year | 2020 |
| Description | NPI database phase II |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | Statistical support |
| Collaborator Contribution | Design, implementation, and analysis |
| Impact | • Firstly we developed a taxonomy with WHO to allow the data to be coded. This taxonomy is now widely used by several other groups who collect their own datasets. So Both within WHO and external groups there are several datasets related to public health and social measures (PHSM) that are based on our taxonomy. • Secondly we developed a set of core variables required and ways of thinking about how we collect this type of policy information. Again these ideas have been adopted and influenced several of the largest trackers which are used widely. • The dataset was the first to bring together data from multiple sources and in doing this we produced mapping between the different groups datasets. We also introduced the idea that this was more sustainable and comprehensive way to collect data. It has led to the other groups establishing a network of PHSM trackers and many groups are now incorporating the same ideas into their datasets • The dataset itself is used by WHO, and is available through their website. They are currently in the process of incorporating the data into their covid19 dashboard. • The data is being used by modellers to look at the impact of policies on the pandemic, we are also using the data to look at what impact completeness of the trackers may have, as we have the ability to compare 5 different trackers. • Finally the dataset is being used to look at ML applications both in terms of automated bring different datasets together, coding existing data and to produce severity indicators |
| Start Year | 2020 |
| Description | Oleylphosphocholine for the treatment of Old World Cutaneous Leishmaniasis(TT4CL) |
| Organisation | St George's University of London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Design of study and analysis of results |
| Collaborator Contribution | Clinical field and lab studies. |
| Impact | None yet. Multidisciplinary: epidemiology, clinical trials, immunology |
| Start Year | 2019 |
| Description | Peek |
| Organisation | Peekvsion |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | Study design, analysis |
| Collaborator Contribution | Technology, programme delivery |
| Impact | Multidisciplinary: statistics, clinical trials |
| Start Year | 2020 |
| Description | Plague in Madagascar |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | trial statistician |
| Collaborator Contribution | design and coordination of the study |
| Impact | None yet. Multidisciplinary: statistics, clinical trials |
| Start Year | 2019 |
| Description | Population estimation methods for PNG |
| Organisation | Medicines for Malaria Venture (MMV) |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Design and analsysis of population estimation |
| Collaborator Contribution | Fieldwork, study coordination, provision of imagery |
| Impact | none yet. Multidisciplinary: Epidemiology, GIS, data science |
| Start Year | 2019 |
| Description | RAFT |
| Organisation | Centre for Research in Infectious Diseases (CRID) |
| Country | Cameroon |
| Sector | Academic/University |
| PI Contribution | Epidemiology lead, study design |
| Collaborator Contribution | Lab studies, entomological expertise, modellers |
| Impact | None yet |
| Start Year | 2020 |
| Description | RAFT |
| Organisation | Cote D'Ivoire's National Institute of Public Health |
| Country | Cote d'Ivoire |
| Sector | Public |
| PI Contribution | Epidemiology lead, study design |
| Collaborator Contribution | Lab studies, entomological expertise, modellers |
| Impact | None yet |
| Start Year | 2020 |
| Description | RAFT |
| Organisation | Imperial College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Epidemiology lead, study design |
| Collaborator Contribution | Lab studies, entomological expertise, modellers |
| Impact | None yet |
| Start Year | 2020 |
| Description | RAFT |
| Organisation | Mahidol University |
| Country | Thailand |
| Sector | Academic/University |
| PI Contribution | Epidemiology lead, study design |
| Collaborator Contribution | Lab studies, entomological expertise, modellers |
| Impact | None yet |
| Start Year | 2020 |
| Description | RAFT |
| Organisation | Malaria Consortium |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | Epidemiology lead, study design |
| Collaborator Contribution | Lab studies, entomological expertise, modellers |
| Impact | None yet |
| Start Year | 2020 |
| Description | RAFT |
| Organisation | National Institute for Medical Research, Tanzania |
| Country | Tanzania, United Republic of |
| Sector | Public |
| PI Contribution | Epidemiology lead, study design |
| Collaborator Contribution | Lab studies, entomological expertise, modellers |
| Impact | None yet |
| Start Year | 2020 |
| Description | Recruitment in stepped wedge trials |
| Organisation | François Rabelais University or University of Tours |
| Country | France |
| Sector | Academic/University |
| PI Contribution | Statistical support |
| Collaborator Contribution | study design and analysis |
| Impact | None yet. Multidisciplinary: statistics, clinical trials |
| Start Year | 2019 |
| Description | Risk of bias in cluster randomized trials |
| Organisation | University of Birmingham |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | PhD student supervision and statistical support |
| Collaborator Contribution | Design and analysis, and supervision |
| Impact | None yet. Multidisciplinary: statistics, clinical trials |
| Start Year | 2019 |
| Description | STICH |
| Organisation | Biomedical Research and Training Institute (BRTI) |
| Country | Zimbabwe |
| Sector | Charity/Non Profit |
| PI Contribution | PI on grant |
| Collaborator Contribution | Co-PI and implementation |
| Impact | None yet |
| Start Year | 2020 |
| Description | SUCCEED |
| Organisation | University of Ibadan |
| Country | Nigeria |
| Sector | Academic/University |
| PI Contribution | Study design |
| Collaborator Contribution | Design, implementation, analysis, interpret |
| Impact | Multidisciplinary: Disability, epidemiology, mental health, clinical trials |
| Start Year | 2020 |
| Description | SUCCEED |
| Organisation | University of Makeni |
| Country | Sierra Leone |
| Sector | Academic/University |
| PI Contribution | Study design |
| Collaborator Contribution | Design, implementation, analysis, interpret |
| Impact | Multidisciplinary: Disability, epidemiology, mental health, clinical trials |
| Start Year | 2020 |
| Description | SUCCEED |
| Organisation | University of Malawi |
| Country | Malawi |
| Sector | Academic/University |
| PI Contribution | Study design |
| Collaborator Contribution | Design, implementation, analysis, interpret |
| Impact | Multidisciplinary: Disability, epidemiology, mental health, clinical trials |
| Start Year | 2020 |
| Description | Scrub typhus India |
| Organisation | Christian Medical College, Vellore |
| Country | India |
| Sector | Academic/University |
| PI Contribution | Design of study and analysis of results |
| Collaborator Contribution | Epidemiology, ecology, one health |
| Impact | https://onlinelibrary.wiley.com/doi/abs/10.1111/tmi.13322 Multidisciplinary: epidemiology, clinical science, entomology, statistics, diagnostic assays |
| Start Year | 2018 |
| Description | Social and behavioral norms related to social protection |
| Organisation | Ipsos MORI |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | Statistical support for sample design and analysis |
| Collaborator Contribution | Ipsos coordinating data collection ; UNICEF funding |
| Impact | Surveys from 7 countries measuring social norms, publications. Multi-disciplinary: epidemiology, public health, qualitative/anthropology |
| Start Year | 2020 |
| Description | Social and behavioral norms related to social protection |
| Organisation | UNICEF |
| Country | United States |
| Sector | Public |
| PI Contribution | Statistical support for sample design and analysis |
| Collaborator Contribution | Ipsos coordinating data collection ; UNICEF funding |
| Impact | Surveys from 7 countries measuring social norms, publications. Multi-disciplinary: epidemiology, public health, qualitative/anthropology |
| Start Year | 2020 |
| Description | Use of CPAP in patients hospitalised with Covid |
| Organisation | Calderdale and Huddersfield NHS Foundation Trust |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Design and analysis |
| Collaborator Contribution | Specialist Covid clinical expertise, data collection |
| Impact | Paper published. Evolving, further study planned to understand the role of CPAP in frail patients with Covid |
| Start Year | 2020 |
| Description | Using pneumococcal carriage and invasiveness to inform vaccine policy in tropical Africa (CB) |
| Organisation | Kenyan Institute for Medical Research (KEMRI) |
| Country | Kenya |
| Sector | Public |
| PI Contribution | study statistician |
| Collaborator Contribution | design and coordination of the study |
| Impact | no papers yet. Multi-disciplinary: epidemiology, genetics, statistics |
| Start Year | 2019 |
| Description | VITALITY |
| Organisation | Biomedical Research and Training Institute (BRTI) |
| Country | Zimbabwe |
| Sector | Charity/Non Profit |
| PI Contribution | Study design, analysis |
| Collaborator Contribution | Study design, implementation and evaluation |
| Impact | Multidisciplinary: clinical medicine, epidemiology, clinical trials, health economics |
| Start Year | 2020 |
| Description | VITALITY |
| Organisation | University of Bristol |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Study design, analysis |
| Collaborator Contribution | Study design, implementation and evaluation |
| Impact | Multidisciplinary: clinical medicine, epidemiology, clinical trials, health economics |
| Start Year | 2020 |
| Description | VITALITY |
| Organisation | University of Lusaka |
| Country | Zambia |
| Sector | Academic/University |
| PI Contribution | Study design, analysis |
| Collaborator Contribution | Study design, implementation and evaluation |
| Impact | Multidisciplinary: clinical medicine, epidemiology, clinical trials, health economics |
| Start Year | 2020 |
| Description | VITALITY |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Study design, analysis |
| Collaborator Contribution | Study design, implementation and evaluation |
| Impact | Multidisciplinary: clinical medicine, epidemiology, clinical trials, health economics |
| Start Year | 2020 |
| Description | Y-CHECK |
| Organisation | National Institute for Medical Research, Tanzania |
| Department | Mwanza Intervention Trials Unit (MITU) |
| Country | Tanzania, United Republic of |
| Sector | Public |
| PI Contribution | Study design |
| Collaborator Contribution | Study design, implementation |
| Impact | Multidisciplinary: epidemiology, public health |
| Start Year | 2018 |
| Description | Y-CHECK |
| Organisation | University of Ghana |
| Country | Ghana |
| Sector | Academic/University |
| PI Contribution | Study design |
| Collaborator Contribution | Study design, implementation |
| Impact | Multidisciplinary: epidemiology, public health |
| Start Year | 2018 |
| Description | Y-CHECK |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | Study design |
| Collaborator Contribution | Study design, implementation |
| Impact | Multidisciplinary: epidemiology, public health |
| Start Year | 2018 |
| Description | Y-CHECK (Zimbabwe) |
| Organisation | Biomedical Research and Training Institute (BRTI) |
| Country | Zimbabwe |
| Sector | Charity/Non Profit |
| PI Contribution | Project lead, study design, analysis |
| Collaborator Contribution | Design, implementation, and analysis |
| Impact | None yet |
| Start Year | 2021 |
| Description | Y-CHECK (Zimbabwe) |
| Organisation | Government of Zimbabwe |
| Department | Ministry of Primary and Secondary Education |
| Country | Zimbabwe |
| Sector | Public |
| PI Contribution | Project lead, study design, analysis |
| Collaborator Contribution | Design, implementation, and analysis |
| Impact | None yet |
| Start Year | 2021 |
| Description | Y-CHECK (Zimbabwe) |
| Organisation | Ministry of Health and Child Welfare of the Republic of Zimbabwe |
| Country | Zimbabwe |
| Sector | Public |
| PI Contribution | Project lead, study design, analysis |
| Collaborator Contribution | Design, implementation, and analysis |
| Impact | None yet |
| Start Year | 2021 |
| Description | Y-CHECK (Zimbabwe) |
| Organisation | University of Zimbabwe |
| Country | Zimbabwe |
| Sector | Academic/University |
| PI Contribution | Project lead, study design, analysis |
| Collaborator Contribution | Design, implementation, and analysis |
| Impact | None yet |
| Start Year | 2021 |
| Description | Y-CHECK (Zimbabwe) |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | Project lead, study design, analysis |
| Collaborator Contribution | Design, implementation, and analysis |
| Impact | None yet |
| Start Year | 2021 |
| Description | Zvatinoda! |
| Organisation | Organization for Public Health Interventions and Development |
| Country | Zimbabwe |
| Sector | Charity/Non Profit |
| PI Contribution | Study design, project coordination |
| Collaborator Contribution | Study design and coordination, fieldwork, liaison with policy makers, digital intervention expertise |
| Impact | none yet. Multidisciplinary: Epidemiology, social science, implementation science |
| Start Year | 2019 |
| Description | Zvatinoda! |
| Organisation | The SHM Foundation |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | Study design, project coordination |
| Collaborator Contribution | Study design and coordination, fieldwork, liaison with policy makers, digital intervention expertise |
| Impact | none yet. Multidisciplinary: Epidemiology, social science, implementation science |
| Start Year | 2019 |
| Title | Eave Tubes |
| Description | Vector control tool which has been evaluated in one CRT; currently searching for funding for a second trial to enable WHO policy decisions |
| Type | Preventative Intervention - Physical/Biological risk modification |
| Current Stage Of Development | Late clinical evaluation |
| Year Development Stage Completed | 2019 |
| Development Status | Actively seeking support |
| Clinical Trial? | Yes |
| Impact | We have generated the first epidemiological evidence for the combined intervention of Eave Tubes and house screening. We measured a 40% decrease in malaria case incidence in children living in villages where the intervention was installed. This evidence has been published in the Lancet and has been reported to WHO to feed into future policy decisions. |
| Title | Next generation bed nets |
| Description | Bed nets with new active ingredients being trialled in CRT in Benin |
| Type | Preventative Intervention - Physical/Biological risk modification |
| Current Stage Of Development | Late clinical evaluation |
| Year Development Stage Completed | 2021 |
| Development Status | Under active development/distribution |
| Impact | Trial is still ongoing so no impact so far |
| Title | Yathu-Yathu |
| Description | Community-based sexual health services for adolescents and young people in Zambia. Community-randomised trial funded by MRC. |
| Type | Health and Social Care Services |
| Current Stage Of Development | Late clinical evaluation |
| Year Development Stage Completed | 2019 |
| Development Status | Under active development/distribution |
| Clinical Trial? | Yes |
| Impact | None yet, trial still in progress. |
| Title | CLAN |
| Description | Command for Stata to conduct a cluster level analysis adjusting for individual level covariates |
| Type Of Technology | Software |
| Year Produced | 2020 |
| Impact | None yet |
| URL | https://ideas.repec.org/c/boc/bocode/s458844.html |
| Title | RtD3 |
| Description | An R package for generating interactive visualisations of rt estimates. Provides an interface for the JavaScript library rt_vis. This package was designed using rt estimates generated by the EpiNow2 package, an open source resource for creating rt estimates. |
| Type Of Technology | Software |
| Year Produced | 2020 |
| Open Source License? | Yes |
| Impact | None yet |
| URL | https://zenodo.org/record/4011842 |
| Title | UK Colocation Dashboard |
| Description | Interactive dashboard of Facebook Colocation data in the UK. |
| Type Of Technology | Software |
| Year Produced | 2020 |
| Open Source License? | Yes |
| Impact | Used by multiple government users as a proxy for differing contact rates in local areas in the UK. Users include: Cabinet Office, Bank of England, Cardiff & Vale NHS Trust. |
| URL | https://cmmid.github.io/colocation_dashboard_cmmid/ |
| Title | pull_facebook_data_for_good |
| Description | Tool to automate data download for researchers using data from Facebook Data for Good. |
| Type Of Technology | Software |
| Year Produced | 2021 |
| Open Source License? | Yes |
| Impact | None yet |
| URL | https://github.com/hamishgibbs/pull_facebook_data_for_good |
| Description | 5th Southern Africa Malaria Research Conference |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Oral presentation presenting results of CRT on reactive focal malaria elimination interventions in Namibia |
| Year(s) Of Engagement Activity | 2019 |
| Description | AMARI Video |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | ARTICULATE "Filling the Gap" is a mental health documentary which highlights the work of selected AMARI fellows in communities as part of their contributions to cut the huge mental health treatment gap. The film also showcases lived experiences of people living with Mental, Neurological and Substance misuse disorders (MNS). |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.youtube.com/watch?v=b_82Zge0-Lg |
| Description | AMR STI Conference |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | 2 day conference tp bring together experts working at the interface of AMR and STI research, policy and practice with a view to identifying bottlenecks and solutions for tackling STI AMR and developing short and long term action plans |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.lshtm.ac.uk/newsevents/events/global-local-addressing-threat-amr-sti-control |
| Description | ASTMH conference (JB) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Oral presentation at ASTMH conference |
| Year(s) Of Engagement Activity | 2019 |
| Description | ASTMH: Symposium on PBO Nets |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Symposium on New Generation Long Lasting Insecticide Treated Nets for malaria prevention |
| Year(s) Of Engagement Activity | 2019 |
| Description | Adolescent Health 2019 Coming of Age |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Prof Helen Weiss, oral presentation at Adolescent Health - Coming of age conference held by RCPCH |
| Year(s) Of Engagement Activity | 2019 |
| Description | BBC world service interview |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | BBC World Service interview in response to second recorded case of "cure" from HIV announced at CROI |
| Year(s) Of Engagement Activity | 2019 |
| Description | BMGF Vector trial design |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Other audiences |
| Results and Impact | Oral presentation re. the Eave Tubes trial to trial design and vector control experts to draw consensus of priorities for future trial design |
| Year(s) Of Engagement Activity | 2020 |
| Description | CROI/ ISSTDR/ IAS 2019 |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Talks on PopART trial results at CROI, IAS and ISSTDR conferences in 2019 |
| Year(s) Of Engagement Activity | 2019 |
| Description | Covid related interviews |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Radio and TV interviews with BBC for advice related to Covid in early days of epidemic in UK and emergence as a global pandemic |
| Year(s) Of Engagement Activity | 2020 |
| Description | Ending Period Poverty Workshop |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Workshop on ending period poverty by 2030, bringing together researchers, funders, policy makers and practitioners to discuss how to use evidence to develop and deliver menstrual health policies and programmes. |
| Year(s) Of Engagement Activity | 2017,2019 |
| Description | Feminem Podcast |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Podcast on careers in epidemiology and gender equity in leadership |
| Year(s) Of Engagement Activity | 2019 |
| Description | HAYA Adolescent health research dissemination |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Following the HAYA research programmed in KwaZulu-Natal, South Africa. Young people co-created and performed songs and films to share messages from the research with their peers and other stakeholders. |
| Year(s) Of Engagement Activity | 2019 |
| Description | HIV: Diverse challenges among children and women in Asia and Africa |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | HIV: Diverse challenges among children and women in Asia and Africa - talk by Dr Fatima Mir (The Aga Khan University, Pakistan) and Prof Gita Ramjee (The Aurum Foundation, South Africa) hosted by STIRIG (LSHTM'S STI Research Interest Group, which is co-directed by ISEG members) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.lshtm.ac.uk/newsevents/events/webinar-hiv-diverse-challenges-among-children-and-women-as... |
| Description | IAS 2018 (KS) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Evaluating uptake of anti-retroviral treatment irrespective of CD4 count |
| Year(s) Of Engagement Activity | 2018 |
| Description | IBS-SSACAB joint conference |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | conference talk |
| Year(s) Of Engagement Activity | 2020 |
| Description | IBS-SSACAB joint conference |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | chaired 1-hour session at IBS-SSACAB Joint conference Cape Town |
| Year(s) Of Engagement Activity | 2019 |
| Description | Immunisation and adolescents - the HPV vaccine |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Speaker discussed where we are at this point with the HPV vaccine programs nationally and globally and what impact we can already see. Event finished with a discussion about attitudes towards the vaccine and how we should deal with potential shortages, as have recently arisen. The event was co-hosted by STIRIG (LSHTM'S STI Research Interest Group, which is co-directed by ISEG members) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.lshtm.ac.uk/newsevents/events/immunisation-and-adolescents-hpv-vaccine |
| Description | Imperial University invited talk |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | Invited seminar to promote good trial methodology |
| Year(s) Of Engagement Activity | 2019 |
| Description | Joint WHO-Wageningen University of Research Global Vector Control Response conference |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Oral Presentation on Insecticides and Malaria Control |
| Year(s) Of Engagement Activity | 2019 |
| Description | Ke Mo Leseding (Into the light), combatting HIV/AIDS stigma in Botswana with innovative approaches |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | This event screened Ke Mo Leseding (Into the light), a film about an intimate and inspirational journey that outlines the story of Stanley Monageng, a 72 year old HIV activist. A message to the people of Botswana, the film tells the story of Stanley's determination to walk over 370 kilometres in just eleven days to provide HIV/AIDS education to the most remote parts of the country. The film featured testament from HIV activists, doctors, political leaders, and community members all pleading Batswana to test and treat for HIV and was followed by a Q&A session with Stanley and the filmmakers. Event hosted by STIRIG (LSHTM'S STI Research Interest Group, which is co-directed by ISEG members) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.lshtm.ac.uk/newsevents/events/ke-mo-leseding-light-combatting-hivaids-stigma-botswana-in... |
| Description | King College invited seminar |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | Invited seminar to promote good trial methodology |
| Year(s) Of Engagement Activity | 2019 |
| Description | Media interviews around release of primary results of PopART trial |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Media interviews around the publication of the primary results of the PopART trial |
| Year(s) Of Engagement Activity | 2019 |
| Description | Mental Health World Congress News |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Other audiences |
| Results and Impact | Interview in Mental Health World Congress Magazine about menstrual health research in the context of school mental health and school drop out |
| Year(s) Of Engagement Activity | 2019 |
| Description | Neisseria gonorrhoeae genomics and antibiotic resistance |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Neisseria gonorrhoeae genomics and antibiotic resistance webinar given by Dr Yonatan Grad (Harvard T.H. Chan) hosted by STIRIG (LSHTM'S STI Research Interest Group, which is co-directed by ISEG members) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.lshtm.ac.uk/newsevents/events/webinar-neisseria-gonorrhoeae-genomics-and-antibiotic-resi... |
| Description | Networking Breakfast |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | TEG networking breakfast at LSHTM - approx 20 LSHTM staff attended a talk designed to promote TEG's work and encourage new collaborations |
| Year(s) Of Engagement Activity | 2019 |
| Description | PIP/AHRI Data workshop |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | Longitudinal nature of data, data collection approach utilized, how to merge such datasets with hospital records of mortalit and also proposed methods of analysis were presented and participants had practical sessions using Stata or R (as per their choice). The purpose was to enabling participants to work on Africa Health Research Institute Population Intervention Programme (PIP) datasets. |
| Year(s) Of Engagement Activity | 2020 |
| Description | Pint of Science (SN) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Public/other audiences |
| Results and Impact | Public talk about trial in Uganda and South Africa, as part of national science festival |
| Year(s) Of Engagement Activity | 2019 |
| Description | PopART and UTT |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Professional Practitioners |
| Results and Impact | Talk at Francis Crick Institute for World AIDS Day 2019 |
| Year(s) Of Engagement Activity | 2019 |
| Description | Programmatic considerations for integrating STI services into pre-exposure prophylaxis (PrEP) programmes |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Dr Jason Ong (Monash University and University of Melbourne) gave a talk on the high prevalence and incidence of sexually transmitted infections (STI) among PrEP users, and how as PrEP programmes continue to be scaled up globally, how many have integrated STI testing into their PrEP programs, and what challenges remain for implementers? Event hosted by STIRIG (LSHTM'S STI Research Interest Group, which is co-directed by ISEG members) |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.lshtm.ac.uk/newsevents/events/programmatic-considerations-integrating-sti-services-pre-e... |
| Description | Punishing the prostitute and protecting the soldier: the Lal Bazaar, lock hospital and the treatment of venereal disease in colonial India |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Talk by Dr Erica Wald, Goldsmiths. The British Army in India had a serious and enduring problem with venereal disease. At any given point across the nineteenth century, roughly 25% of its European troops were in hospital, with some form of what were known as 'vice'-related illnesses, the most frequently diagnosed of which was syphilis. In response to this, medical and commanding offers joined forces to construct a punitive treatment system which targeted the women seen to be the root cause of this problem - those Indian women deemed to be 'common prostitutes'. However, the system continually failed to accomplish any of its aims.The talk explored the construction, operation and consequences of the ways in which syphilis was approached in the nineteenth century. Hosted by STIRIG (LSHTM'S STI Research Interest Group, which is co-directed by ISEG members) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.lshtm.ac.uk/newsevents/events/punishing-prostitute-and-protecting-soldier-lal-bazaar-loc... |
| Description | SADC E8 Webinar |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Professional Practitioners |
| Results and Impact | Inaugural Webinar of SADC Malaria Elimonation Eight: Talk on impact of malaria border health posts |
| Year(s) Of Engagement Activity | 2020 |
| Description | STI Vaccine Workshop |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Workshop on the need for STI vaccines/bottlenecks for development & implementation, bringing together researchers, policy makers and clinicians |
| Year(s) Of Engagement Activity | 2019 |
| URL | https://www.lshtm.ac.uk/newsevents/events/sti-vaccine-workshop-innovations-impact |
| Description | STI co-endemicity and the role of point of care tests for resistance guided therapy |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | This seminar discussed the outcomes of the 'Precise' study, which aimed to develop point of care antimicrobial resistance tests for Neisseria gonorrhoeae and Mycoplasma genitalium infection to ensure accurate resistance guided therapy and antibiotic stewardship in sexual health medicine. Data also presented from a sub-study looking at STI co-infections, macrolide resistance and risk factors associated with MG infection. The talk was hosted by STIRIG (LSHTM'S STI Research Interest Group, which is co-directed by ISEG members) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.lshtm.ac.uk/newsevents/events/sti-co-endemicity-and-role-point-care-tests-resistance-gui... |
| Description | SUSAN-SSACAB conference |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Six previous TEG fellows attended, presented abstracts & discussed to strengthen the network, to share expertise, collaborate on common projects. Also contributed to discussions on how TEG can contribute to the SSACAB initiative for capacity building in SSA |
| Year(s) Of Engagement Activity | 2019 |
| Description | Seminar "Interpretation (and mis-interpretation) of p-values" |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Other audiences |
| Results and Impact | talk as part of monthly seminar series for research community associated with MRC Uganda. |
| Year(s) Of Engagement Activity | 2020 |
| Description | Single-Dose HPV Vaccine Evaluation Consortium |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | member of advisory group |
| Year(s) Of Engagement Activity | 2020 |
| Description | Stockholm Convention DDT Expert Group |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Advise the Conference of the Parties to the Stockholm Convention on continued use of DDT for malaria vector control |
| Year(s) Of Engagement Activity | 2020 |
| Description | Talks on PopART trial results |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | Talks on PopART trial results given at University of Third Age, Francis Crick Institute and other organizations |
| Year(s) Of Engagement Activity | 2019 |
| Description | Television Interview on ENCA, South Africa |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Public/other audiences |
| Results and Impact | Interview during Evening News on South Africa's main news channel (ENCA) on results of malaria trial in Namibia |
| Year(s) Of Engagement Activity | 2020 |
| Description | The Behaviour Insights Team stepped wedge trial talk |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | Invited seminar at a social purpose company part owned by the cabinet office to promote good trial methodology |
| Year(s) Of Engagement Activity | 2019 |
| Description | The elimination of cervical cancer should not be a dream but critical basic elements are still needed |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Talk byDr Silvia de Sanjosé, US National Cancer Institute. Talk summary: Recently WHO has launched a call to eliminate cervical cancer globally during this century. The joint impact of HPV vaccines and adequate cervical cancer screening and treatment are the pillars for this announcement. The reality is, however, surprisingly behind. Less that 15% of women in LMIC have ever had a screening test and still the majority of girls in the world have not yet been vaccinated. Further, many women living with HIV in low and middle income countries (LMIC) are not receiving an optimal screening approach. Limiting screening to 1 or 2 visits lifetime requires a highly accurate approaches still largely unavailable. Recent scientific developments on the impact of HPV type specific infections and on the use of artificial intelligence based methods to evaluate cervical images in the screening setting open new realistic venues. Talk hosted by STIRIG (LSHTM'S STI Research Interest Group, which is co-directed by ISEG members) Speaker Dr Silvia de Sanjosé, MD and PhD from LSHTM, is a senior Consultant at the US National Cancer Institute (NCI) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.lshtm.ac.uk/newsevents/events/elimination-cervical-cancer-should-not-be-dream-critical-b... |
| Description | WHO DAT Task force |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | WHO Digital Adherence Technology Task force for TB. |
| Year(s) Of Engagement Activity | 2020 |
| Description | WHO Malariogenic potential |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Other audiences |
| Results and Impact | WHO Expert Review Group re Malariogenic potential: stratification after elimination- invited expert |
| Year(s) Of Engagement Activity | 2019 |
| Description | WHO VCAG |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | WHO Vector Control Advisory Group |
| Year(s) Of Engagement Activity | 2020 |
| Description | WHO VCAG |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | WHO Vector Control Advisory Group |
| Year(s) Of Engagement Activity | 2020 |
| Description | WHO/UNAIDS/UT3C |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | WHO/UNAIDS consultation with UTT trial investigators to discuss policy implications of trials of universal testing and treatment for HIV |
| Year(s) Of Engagement Activity | 2019 |
| Description | World Health Organization strategic approaches to sexually transmitted infections prevention and control: a historical perspective |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Dr Francis Ndowa, Regional Director of the Africa and the Middle East & North Africa Branch of the International Union against STIs (IUSTI Africa-MENA), a member of the WHO Sexual and Reproductive Health/Human Reproduction (SRH/HRP) Scientific and Technical Advisory Group delivered a seminar outlining key milestones, features and recommendations presented by the World Health Organization (WHO) in response to the burden of sexually transmitted infections at the global and national levels historically, highlighting successes and recognised gaps, in both research and interventions. The talk also looked at policies and opportunities which enhance or hinder the global and national responses to sexually transmitted infections (STI) prevention and control. Seminar hosted by hosted by STIRIG (LSHTM'S STI Research Interest Group, which is co-directed by ISEG members) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.lshtm.ac.uk/newsevents/events/world-health-organization-strategic-approaches-sexually-tr... |
| Description | Young Scientists (SN) |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Schools |
| Results and Impact | Around 12-20 local school pupils (age 14-18) attend LSHTM for 1-2 weeks. They design and carry out a piece of scientific research, supported by academic staff and postgraduate student mentors. They then present their results to an open seminar. Held three times per year. |
| Year(s) Of Engagement Activity | 2019 |
| Description | anti-microbial resistance symposium |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Other audiences |
| Results and Impact | Gave a talk at the anti-microbial resistance symposium at LSHTM about developing drug resistance to malaria treatment in the Greater Mekong region |
| Year(s) Of Engagement Activity | 2019 |